September is the WORST month for stocks
1 extracted signal · 0 resolved · 1 still active
Traders Helping TradersIndependent analyst profile- Source published
- 18 Aug 2026, 22:00 UTC
- Recorded by Tahlil Plus
- 18 Aug 2026, 23:42 UTC
AI-generated source summary
The analysis focuses on the potential short-term sell-off and correction in SPY and QQQ. SPY is noted to be in a long-term bullish cycle but is showing signs of a potential 2-3% pullback in the next month. QQQ is currently trading within an institutional sell zone and faces resistance. A key support level for QQQ is identified around 705, with a break below this level potentially leading to further downside. The historical data for August suggests it's a weaker month for the market, with SPY averaging a slight loss. The speaker emphasizes looking for opportunities to buy dips if the market corrects, rather than fearing small pullbacks. The analysis considers seasonality as a secondary factor, noting August and September as historically weaker months for QQQ and SPY respectively. The primary prediction is a short-term bearish move for both indices, targeting lower levels before potentially resuming the long-term bullish trend.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Traders Helping Traders
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.